Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:DJ
|
| gptkbp:associated_with |
increased transmissibility
increased mortality risk long COVID symptoms potential for reinfection |
| gptkbp:campaigns |
adjustments made to strategies
|
| gptkbp:collaborations |
international research collaboration
|
| gptkbp:community |
significant community spread observed
|
| gptkbp:community_impact |
affected global pandemic response
social and economic impacts observed |
| gptkbp:data_usage |
higher than original strain
|
| gptkbp:descendant |
B.1.1.7 lineage
|
| gptkbp:designated_as |
Variant of Concern
|
| gptkbp:discovered_by |
gptkb:United_Kingdom
|
| gptkbp:exported_to |
multiple countries
|
| gptkbp:first_described_by |
December 2020
|
| gptkbp:genetic_diversity |
gptkb:N501_Y
P681 H affects binding to AC E2 receptor del69-70 |
| gptkbp:healthcare |
increased testing and contact tracing
need for public education on variants significant concern for outbreaks strain on healthcare systems |
| https://www.w3.org/2000/01/rdf-schema#label |
Alpha variant
|
| gptkbp:is_known_for |
gptkb:B.1.1.7
|
| gptkbp:is_monitored_by |
continuously monitored by WHO
genomic surveillance essential important for future variants |
| gptkbp:is_popular_in |
widespread in many countries
|
| gptkbp:is_recognized_by |
September 2020
|
| gptkbp:is_vulnerable_to |
influenced vaccine development strategies
may require booster shots reduced against symptomatic infection reduced effectiveness |
| gptkbp:notable_work |
studies published in scientific journals
|
| gptkbp:origin |
mutations in spike protein
evolving with new mutations |
| gptkbp:provides_information_on |
updated to address variant spread
|
| gptkbp:public_awareness |
increased media coverage
|
| gptkbp:research_focus |
ongoing studies on transmissibility
|
| gptkbp:responds_to |
coordinated global response required
|
| gptkbp:scientific_classification |
Variant of Interest before Variant of Concern
|
| gptkbp:scientific_name |
gptkb:SARS-Co_V-2_B.1.1.7
|
| gptkbp:seating_capacity |
travel restrictions implemented
|
| gptkbp:side_effect |
increased hospitalizations
|
| gptkbp:symptoms |
similar to original COVID-19 symptoms
|
| gptkbp:track |
tracked by public health agencies
|
| gptkbp:variant |
characterized by specific mutations
compared to other variants distinct genetic characteristics utilized for tracking variants. |
| gptkbp:bfsParent |
gptkb:virus
gptkb:COVID-19_Pandemic gptkb:COVID-19 gptkb:COVID-19_pandemic |
| gptkbp:bfsLayer |
4
|